<p>PureTech Health plc (NASDAQ:PRTC - 獲取免費報告) 的股價在週一開盤前出現了跳空上漲。該股上一個收盤價為 22.45 美元，但開盤價為 23.06 美元。PureTech Health 的股票最新交易價為 24.00 美元，成交量為 2,101 股。</p>
<p>獲取 <strong>PureTech Health</strong> 警報：</p>
<h2>PureTech Health 價格表現</h2>
<p>該股的五十日移動平均價格為 23.20 美元，兩百日移動平均價格為 25.86 美元。</p>
<h2>機構資金流入和流出</h2>
<p>一家機構投資者最近在 PureTech Health 股票中建立了新頭寸。根據最新提交給證券交易委員會（SEC）的 13F 文件，Birch Hill Investment Advisors LLC 在第二季度購入了 PureTech Health plc (NASDAQ:PRTC - 免費報告) 的新頭寸。該公司購入了該公司的 302,000 股股票，價值約為 7,550,000 美元。截至最近一次提交給證券交易委員會（SEC）的文件，Birch Hill Investment Advisors LLC 擁有 PureTech Health 約佔公司股份的 1.26%。機構投資者和對沖基金持有該股的 0.04%。</p>
<h2>關於 PureTech Health（獲取免費報告）</h2>
<p>PureTech Health plc 在美國從事生物技術和製藥解決方案的開發和商業化。該公司正在開發處於第 2 階段的 LYT-100，用於治療特發性肺纖維化（IPF）；以及處於第 1/2 階段的 IgG4 單克隆抗體 LYT-200，針對固體腫瘤和血液惡性腫瘤的靶向葡聚糖結合蛋白-9。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們比 PureTech Health 更喜歡的股票</li>
<li>投資者如何從盤後交易中受益</li>
<li>為大多數投資者最佳的買入持有策略</li>
<li>股票分拆意味着什麼？</li>
<li>艾利·莉莉通往下一個萬億市值的道路</li>
<li>通過這些股息王度過衰退</li>
<li>Mobileye Global：CEO 對未來實力押注 1000 萬美元</li>
</ul>
<p>_此即時新聞警報由敍事科技生成，並結合了來自 MarketBeat 的財務數據，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</p>
<p>→ 卡瑪拉·哈里斯會拖累市場嗎？（來自 Paradigm Press）（廣告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjY2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjY2"/></p>
<h2>現在是否值得投資 1,000 美元購買 PureTech Health 股票？</h2>
<p>在考慮購買 PureTech Health 股票之前，您需要聽到這個消息。</p>
<p>MarketBeat 持續追蹤華爾街評級最高且表現最佳的研究分析師以及他們每天向客户推薦的股票。MarketBeat 已確定了五隻頂級分析師悄悄告訴客户在更廣泛市場注意之前購買的股票... 而 PureTech Health 不在名單上。</p>
<p>儘管 PureTech Health 目前在分析師中有一個 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

PRTC

<p>PureTech Health plc (NASDAQ:PRTC) 股票在週一市場開盤前跳空至 0.45 美元，較上一個收盤價 0.06 美元上漲。該股最新交易價為 0.00 美元，成交量為 2,101 股。Birch Hill Investment Advisors LLC 最近收購了該公司的 302,000 股股票，價值約 55 萬美元。PureTech Health 開發生物製藥解決方案，目前正在推進兩種產品進行臨牀試驗，用於治療嚴重健康狀況</p>

<p>PureTech Health plc (NASDAQ:PRTC - Get Free Report)'s share price gapped up before the market opened on Monday . The stock had previously closed at $22.45, but opened at $23.06. PureTech Health shares last traded at $24.00, with a volume of 2,101 shares.</p>
<div class="lb-trans"><p>PureTech Health plc (NASDAQ:PRTC - 獲取免費報告) 的股價在週一開盤前出現了跳空上漲。該股上一個收盤價為 22.45 美元，但開盤價為 23.06 美元。PureTech Health 的股票最新交易價為 24.00 美元，成交量為 2,101 股。</p>
</div><p>Get <strong>PureTech Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>PureTech Health</strong> 警報：</p>
</div><h2>PureTech Health Price Performance</h2>
<div class="lb-trans"><h2>PureTech Health 價格表現</h2>
</div><p>The stock has a fifty day moving average price of $23.20 and a two-hundred day moving average price of $25.86.</p>
<div class="lb-trans"><p>該股的五十日移動平均價格為 23.20 美元，兩百日移動平均價格為 25.86 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>An institutional investor recently bought a new position in PureTech Health stock. Birch Hill Investment Advisors LLC bought a new position in shares of PureTech Health plc (NASDAQ:PRTC - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 302,000 shares of the company's stock, valued at approximately $7,550,000. Birch Hill Investment Advisors LLC owned about 1.26% of PureTech Health as of its most recent filing with the Securities and Exchange Commission (SEC). 0.04% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一家機構投資者最近在 PureTech Health 股票中建立了新頭寸。根據最新提交給證券交易委員會（SEC）的 13F 文件，Birch Hill Investment Advisors LLC 在第二季度購入了 PureTech Health plc (NASDAQ:PRTC - 免費報告) 的新頭寸。該公司購入了該公司的 302,000 股股票，價值約為 7,550,000 美元。截至最近一次提交給證券交易委員會（SEC）的文件，Birch Hill Investment Advisors LLC 擁有 PureTech Health 約佔公司股份的 1.26%。機構投資者和對沖基金持有該股的 0.04%。</p>
</div><h2>About PureTech Health (Get Free Report)</h2>
<div class="lb-trans"><h2>關於 PureTech Health（獲取免費報告）</h2>
</div><p>PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.</p>
<div class="lb-trans"><p>PureTech Health plc 在美國從事生物技術和製藥解決方案的開發和商業化。該公司正在開發處於第 2 階段的 LYT-100，用於治療特發性肺纖維化（IPF）；以及處於第 1/2 階段的 IgG4 單克隆抗體 LYT-200，針對固體腫瘤和血液惡性腫瘤的靶向葡聚糖結合蛋白-9。</p>
</div><h2>Recommended Stories</h2>
<ul>
<li>Five stocks we like better than PureTech Health</li>
<li>How Can Investors Benefit From After-Hours Trading</li>
<li>Why the Buy-and-Hold Strategy May Be Best for Most Investors</li>
<li>What Does a Stock Split Mean?</li>
<li>Eli Lilly’s Path to the Next Trillion Market Capitalization</li>
<li>Ride Out The Recession With These Dividend Kings</li>
<li>Mobileye Global: CEO Makes $10 Million Bet on Future Strength</li>
</ul>
<div class="lb-trans"><h2>推薦故事</h2>
<ul>
<li>五隻我們比 PureTech Health 更喜歡的股票</li>
<li>投資者如何從盤後交易中受益</li>
<li>為大多數投資者最佳的買入持有策略</li>
<li>股票分拆意味着什麼？</li>
<li>艾利·莉莉通往下一個萬億市值的道路</li>
<li>通過這些股息王度過衰退</li>
<li>Mobileye Global：CEO 對未來實力押注 1000 萬美元</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p>_此即時新聞警報由敍事科技生成，並結合了來自 MarketBeat 的財務數據，旨在為讀者提供最快速和最準確的報道。本故事在發佈前經過 MarketBeat 編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com。</p>
</div><p>→ Kamala Harris To Tank the Market? (From Paradigm Press)(Ad)</p>
<div class="lb-trans"><p>→ 卡瑪拉·哈里斯會拖累市場嗎？（來自 Paradigm Press）（廣告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MjY2" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9266&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in PureTech Health right now?</h2>
<div class="lb-trans"><h2>現在是否值得投資 1,000 美元購買 PureTech Health 股票？</h2>
</div><p>Before you consider PureTech Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮購買 PureTech Health 股票之前，您需要聽到這個消息。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 持續追蹤華爾街評級最高且表現最佳的研究分析師以及他們每天向客户推薦的股票。MarketBeat 已確定了五隻頂級分析師悄悄告訴客户在更廣泛市場注意之前購買的股票... 而 PureTech Health 不在名單上。</p>
</div><p>While PureTech Health currently has a &#34;hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 PureTech Health 目前在分析師中有一個 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

PureTech Health（納斯達克代碼：PRTC）股價跳空上漲至 22.45 美元